URGENT: This Altcoin Opportunity Won’t Wait – Act Now

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

RGLS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.35%

Insider Buying (Last 12 Months): $7,280.00

Insider Selling (Last 12 Months): $23,857.12

Regulus Therapeutics Insider Trading History Chart

Regulus Therapeutics Share Price & Price History

^$1.59

▲ +0.04 (2.58%)

As of 12/20/2024 06:16 PM ET

Days: 30 | 90 | 365

$2 Trillion Disappears Because of Fed's Secretive New Move

From Stansberry Research | Ad

$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.

Click here to see his new research now.

Regulus Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/25/2024	Kathryn J Collier	Director	Buy	4,000	$1.82	$7,280.00	6,740
1/18/2024	Crispina Calsada	CFO	Sell	5,468	$1.19	$6,506.92	5,782
1/18/2024	Joseph P. Hagan	CEO	Sell	14,580	$1.19	$17,350.20	57,112
2/4/2022	Denis Drygin	Insider	Buy	23,314	$0.23	$5,362.22
1/26/2022	Joseph P. Hagan	CEO	Buy	100,000	$0.22	$22,000.00

$2 Trillion Disappears Because of Fed's Secretive New Move

From Stansberry Research | Ad

Click here to see his new research now.

SEC Filings (Institutional Ownership Changes) for Regulus Therapeutics (NASDAQ:RGLS)

92.38% of Regulus Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Regulus Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/19/2024	Barclays PLC	84,477	$0.13M	0.0%	+285.2%	0.129%
11/16/2024	Geode Capital Management LLC	1,280,567	$2.01M	0.0%	-4.0%	1.955%
11/15/2024	Barclays PLC	84,477	$0.13M	0.0%	+285.2%	0.129%
11/15/2024	Jane Street Group LLC	29,580	$46K	0.0%	N/A	0.045%
11/15/2024	State Street Corp	1,000,998	$1.57M	0.0%	+3.5%	1.528%
11/15/2024	RA Capital Management L.P.	766,834	$1.20M	0.0%	-87.7%	1.171%
11/15/2024	Point72 Asset Management L.P.	893,762	$1.40M	0.0%	N/A	1.365%
11/14/2024	NEA Management Company LLC	6,467,802	$10.15M	0.6%	N/A	9.875%
11/13/2024	FMR LLC	328,157	$0.52M	0.0%	-83.8%	0.501%
11/13/2024	The Manufacturers Life Insurance Company	129,700	$0.20M	0.0%	N/A	0.198%
11/5/2024	Victory Capital Management Inc.	398,866	$0.63M	0.0%	+10.4%	0.609%
10/25/2024	Tyche Wealth Partners LLC	106,089	$0.17M	0.0%	+920.6%	0.162%
10/11/2024	Creative Planning	16,466	$26K	0.0%	N/A	0.025%
10/3/2024	SG Americas Securities LLC	20,800	$33K	0.0%	N/A	0.032%
8/15/2024	CVI Holdings LLC	401,012	$0.72M	0.6%	-71.5%	0.613%
8/9/2024	Renaissance Technologies LLC	118,100	$0.21M	0.0%	+56.4%	0.180%
8/5/2024	Victory Capital Management Inc.	361,386	$0.65M	0.0%	-1.8%	0.552%
8/1/2024	Rhumbline Advisers	76,472	$0.14M	0.0%	N/A	0.117%
7/26/2024	Bank of New York Mellon Corp	197,193	$0.35M	0.0%	N/A	0.301%
5/29/2024	Opaleye Management Inc.	170,308	$0.49M	0.1%	N/A	0.260%
5/17/2024	RA Capital Management L.P.	6,250,000	$18M	0.2%	N/A	9.547%
5/15/2024	NEA Management Company LLC	6,467,802	$18.63M	1.1%	N/A	9.879%
5/10/2024	Vanguard Group Inc.	740,215	$2.13M	0.0%	+158.4%	1.131%
5/7/2024	CVI Holdings LLC	1,406,250	$4.05M	3.9%	N/A	2.148%
4/22/2024	Vivo Capital LLC	5,000,000	$14.40M	1.1%	N/A	7.638%
2/5/2024	Victory Capital Management Inc.	271,736	$0.35M	0.0%	+16.5%	1.344%
11/13/2023	FMR LLC	2,922,600	$4.03M	0.0%	+32.4%	14.454%
11/6/2023	Victory Capital Management Inc.	233,207	$0.32M	0.0%	+5.3%	1.197%
8/14/2023	Prelude Capital Management LLC	40,660	$60K	0.0%	N/A	0.209%
9/16/2022	Federated Hermes Inc.	2,904,826	$6.01M	0.0%	-90.0%	19.850%
8/16/2022	DAFNA Capital Management LLC	555,555	$1.15M	0.3%	-90.0%	3.797%
8/12/2022	Ikarian Capital LLC	105,341	$0.22M	0.0%	-91.8%	0.722%
8/1/2022	Victory Capital Management Inc.	221,506	$0.46M	0.0%	-90.1%	1.517%
7/19/2022	Commonwealth Equity Services LLC	22,000	$45K	0.0%	-83.2%	0.151%
2/14/2022	DAFNA Capital Management LLC	5,555,555	$1.75M	0.4%	N/A	6.382%
1/19/2022	Asymmetry Capital Management L.P.	2,731,044	$0.86M	0.5%	+94.9%	3.137%
11/15/2021	GSA Capital Partners LLP	64,708	$45K	0.0%	-68.6%	0.074%
11/4/2021	Asymmetry Capital Management L.P.	1,401,491	$0.97M	0.6%	-3.4%	1.610%
10/29/2021	Commonwealth Equity Services LLC	111,000	$76K	0.0%	+38.8%	0.128%
9/17/2021	Virtu Financial LLC	79,193	$64K	0.0%	N/A	0.091%
8/27/2021	Endurant Capital Management LP	2,607,674	$2.12M	0.6%	+9.7%	2.996%
8/16/2021	State Street Corp	176,494	$0.14M	0.0%	N/A	0.203%
8/13/2021	Geode Capital Management LLC	589,196	$0.48M	0.0%	+54.3%	0.786%
8/13/2021	Vanguard Group Inc.	3,095,237	$2.52M	0.0%	-3.9%	4.131%
8/12/2021	Lido Advisors LLC	57,500	$47K	0.0%	N/A	0.077%
8/11/2021	Commonwealth Equity Services LLC	80,000	$65K	0.0%	+300.0%	0.107%
8/10/2021	Strategic Wealth Advisors Group LLC	74,800	$61K	0.0%	N/A	0.100%
8/5/2021	GSA Capital Partners LLP	206,265	$0.17M	0.0%	N/A	0.275%
7/31/2021	Asymmetry Capital Management L.P.	1,450,777	$1.18M	0.8%	-26.9%	1.936%
7/15/2021	Focused Wealth Management Inc	200,000	$0.16M	0.0%	+100.0%	0.267%
5/19/2021	Squarepoint Ops LLC	159,804	$0.25M	0.0%	+1,477.7%	0.213%
5/17/2021	Endurant Capital Management LP	2,376,557	$3.71M	1.0%	N/A	3.172%
5/17/2021	Ikarian Capital LLC	1,245,989	$1.94M	0.1%	N/A	1.663%
5/17/2021	Atom Investors LP	337,228	$0.53M	0.1%	N/A	0.450%
5/17/2021	Goldman Sachs Group Inc.	18,049	$28K	0.0%	-68.0%	0.024%
5/12/2021	Northern Trust Corp	117,654	$0.18M	0.0%	+198.4%	0.157%
5/12/2021	Geode Capital Management LLC	381,892	$0.60M	0.0%	+493.5%	0.510%
5/11/2021	Acadian Asset Management LLC	465,678	$0.73M	0.0%	N/A	0.622%
5/11/2021	Asymmetry Capital Management L.P.	1,985,472	$3.10M	1.6%	N/A	2.650%
5/4/2021	Commonwealth Equity Services LLC	20,000	$31K	0.0%	N/A	0.027%
5/4/2021	Victory Capital Management Inc.	2,227,199	$3.47M	0.0%	+345.4%	2.976%
5/3/2021	Focused Wealth Management Inc	100,000	$0.16M	0.0%	N/A	0.134%
2/10/2021	Renaissance Technologies LLC	449,200	$0.61M	0.0%	N/A	1.147%
2/5/2021	BlackRock Inc.	49,788	$68K	0.0%	-23.2%	0.127%
2/2/2021	Grimes & Company Inc.	54,511	$74K	0.0%	+127.1%	0.139%
2/2/2021	GYL Financial Synergies LLC	51,376	$69K	0.0%	N/A	0.131%
2/1/2021	Victory Capital Management Inc.	499,989	$0.68M	0.0%	N/A	1.277%

Data available starting January 2016

Regulus Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RGLS8429, an anti-miR next generation oligonucleotide targeting miR-17, which is in Phase 1b clinical trial for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Today's Range

Now: $1.59

$1.51

$1.60

50 Day Range

MA: $1.53

$1.40

$1.70

52 Week Range

Now: $1.59

$1.08

$3.79

Volume

462,262 shs

Average Volume

1,154,690 shs

Market Capitalization

$104.15 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.61

Who are the company insiders with the largest holdings of Regulus Therapeutics?: Regulus Therapeutics' top insider investors include:
Joseph P Hagan (CEO)
Kathryn J Collier (Director)
Crispina Calsada (CFO)
Learn More about top insider investors at Regulus Therapeutics.
Who are the major institutional investors of Regulus Therapeutics?: Regulus Therapeutics' top institutional investors include:
NEA Management Company LLC — 9.87%
Geode Capital Management LLC — 1.96%
State Street Corp — 1.53%
Point72 Asset Management L.P. — 1.36%
RA Capital Management L.P. — 1.17%
Victory Capital Management Inc. — 0.61%
Learn More about top institutional investors of Regulus Therapeutics stock.
Which institutional investors are selling Regulus Therapeutics stock?: During the previous quarter, RGLS stock was sold by these institutional investors:
RA Capital Management L.P.
FMR LLC
Geode Capital Management LLC
In the last year, company insiders that have sold Regulus Therapeutics company stock include:
Joseph P Hagan (CEO)
Kathryn J Collier (Director)
Learn More investors selling Regulus Therapeutics stock.
Which institutional investors are buying Regulus Therapeutics stock?: In the previous quarter, RGLS stock was acquired by institutional investors including:
NEA Management Company LLC
Point72 Asset Management L.P.
The Manufacturers Life Insurance Company
Tyche Wealth Partners LLC
Barclays PLC
Barclays PLC
Victory Capital Management Inc.
State Street Corp